Research output per year
Research output per year
dr.
Lundlaan 6, Wilhemina Children's Hospital
3584 EA Utrecht
Netherlands
Heidelberglaan 100, UMC Utrecht
3584 CX Utrecht
Netherlands
Research activity per year
Joost Swart is a board certified paediatrician immunologist & rheumatologist. After receiving his Medical Degree (cum laude/ with Honour) from the University of Groningen in 1999, he finished his training as a paediatrician at the VU Medical Center in Amsterdam in 2006. His fellowship paediatric rheumatology-immunology was completed in 2008 in Utrecht. He worked as a paediatric rheumatologist for 3 years in both Reade and the VUmc in Amsterdam. In 2011 he came to work in the largest Dutch group of Pediatric Rheumatology / Immunology based in Utrecht. He is currently doing a Master in Epidemiology at Utrecht University.
His research (and that of his PhD-students) focuses on comparative effectiveness and safety of drugs, treatment-strategies and eHealth in juvenile idiopathic arthritis (JIA). He also analysed the effects of mesenchymal stem cells in JIA-patients. Furthermore he is researcher and member of the Steering Committee of the international Pharmacovigilance database Pharmachild (over 9000 JIA-patients who have contributed their clinical data and thousands of blood and synovial samples) and is co-P.I. of the UCAN CAN-DU project (JIA project involving all academic paediatric rheumatology centers in the Netherlands and Canada). https://www.ucancandu.com/
He is (co-)author on more than 60 scientific articles in peer-reviewed journals, mostly related to JIA. He is (co-)applicant on multiple successful research grants (e.g. UCAN CAN-DU. Real-life integration of innovative precision medicine strategies into care provision will forever transform the care of children with arthritis in our countries and beyond. Canadian Institutes of Health Research/ The Netherlands Organisation for Health Research and Development [ZonMw]/ Dutch Arthritis Foundation funded €5,500,000).
He is council member of the Dutch Association for Paediatric Rheumatology, council member of the Pediatric Rheumatology International Trial Organization and chair of the Pharmacovigilance and Targeted Therapies Working Party of ERN-RITA. He is member of the Dutch Pediatric Association, Dutch Rheumatology Association, Paediatric Rheumatology European Society, and the Dutch Association against Quackery.
He educates students in both the CRU and Summa medical curricula in Utrecht. He trains interns, residents and fellows in paediatrics and rheumatology in UMC Utrecht. He is a certified instructor on the APLS-course from the Advance Life Support Group.
-Chair of Pharmacovigilance Working Party, European Reference Network, Rare Immunodeficiencies, AutoImmune and AutoInflammatory Diseases (ERN RITA)
-Co-chair of Clinical Guidelines Working Party, ERN RITA
-Council Member for the Paediatric Rheumatology International Trials Organisation (PRINTO)
Board member of the Dutch Pediatric Rheumatology Association
-National coordinator Pediatric Rheumatology International Trials Organization (Printo)
-Member of the European Medicines Agency (EMA) Working Party with Healthcare Professionals on behalf of European League against Rheumatism (EULAR)
-Member of JIA Working Group of Outcome Measures in Rheumatology (OMERACT)
-Member of the SHARE initiative European consensus-based recommendations for
the diagnosis and treatment of JIA
-Member of Digital Health Working Party of Dutch Rheumatology Association (NVR)
-Member of Steering Committee of UCAN CAN-DU
-Member of Steering Committee of PharmaChild
-Member of Data Safety Monitoring Board STARS Trial (PRINTO study with PI: Dr Consolaro)
-Member of Digital Health Working Party of Dutch Rheumatology Association (NVR)
-Utrecht representative of Dutch Paediatric Clinical Trial Network (Pedmed-NL)
2015 “The Addition of one or more Biologics to Methotrexate in Children with JIA increases the Incidence of
Infections and Serious Adverse Events. The 5882 Pharmachild Cohort.” Selected as Top 6 of Clinical
Science Abstracts chosen from 4323 Abstracts EULAR Congress Rome
2010 “Mesenchymal Stem Cell Therapy has significant Clinical and Histopathological Effect in Proteoglycan
Induced Arthritis” Selected as Top 25 of Basic Science Abstracts chosen from 3,508 Abstracts EULAR
Congress Rome
2009 Teaching Award for Excellence in Clinical Teaching, Dep. of Paediatrics, VUmc Amsterdam
2002 Resident Teaching Award for Excellence in Clinical Teaching, Dep. of Paediatrics,
Deventer Hospitals, NL
Research output: Contribution to journal › Article › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review
Research output: Contribution to journal › Article › Academic › peer-review
JF Swart (Speaker)
Activity: Talk or presentation › Invited talk › Professional
JF Swart (Speaker) & SJ Vastert (Speaker)
Activity: Talk or presentation › Invited talk › Academic
JF Swart (Speaker)
Activity: Talk or presentation › Invited talk › Academic
JF Swart (Interviewee)
Activity: Other › Types of Public engagement and outreach - Media article or participation
JF Swart (Interviewee)
Activity: Other › Types of Public engagement and outreach - Media article or participation
Swart, Joost (Recipient), Sept 2014
Prize: Prize (including medals and awards)
2/11/17
1 Media contribution
Press/Media: Public Engagement Activities
Nico M. Wulffraat, JF Swart & SJ Vastert
1/04/17
1 Media contribution
Press/Media: Expert Comment
1/01/17 → 1/01/17
2 Media contributions
Press/Media: Expert Comment
Wulffraat, N. M., van Loosdregt, J., Takken, T., Swart, J. & Klein, M.
1/01/17
1 Media contribution
Press/Media: Expert Comment